HIV/AIDS patients' knowledge, attitude, and practice toward anti-retroviral therapy medications' adverse effects and associated factors in Tikur Anbessa Specialized Hospital [0.03%]
艾滋病人对逆转录病毒治疗药物副作用的认知、态度和行为及影响因素：在蒂库尔安贝萨专科医院的研究
Zenebe Negash,Yohannes Yibeltal,Akeberegn Gorems Ayele
Zenebe Negash
Background: Adverse effects (AEs) have been reported with all antiretroviral therapy (ART) medications, and it was among the most common cause for switching or terminating therapy and drug non-adherence. Even though AEs o...
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance [0.03%]
信息流行病时代下的自我药疗实践的改善及药品警戒的作用
Carlos-Alberto Calderon-Ospina
Carlos-Alberto Calderon-Ospina
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers [0.03%]
网络药店中抗癌和免疫调节治疗的潜在自我药疗药物相互作用的临床意义
Florian Schindler,Timo Schinkoethe,Sven Mahner et al.
Florian Schindler et al.
Background: Modern oral antineoplastic and immune-modulating drugs offer an array of therapeutic advantages, and yet pose challenges in daily use for patients, physicians and pharmacists. In contrast to intravenous admini...
Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries [0.03%]
药物警戒的筹资和财务可持续性：资源匮乏非洲国家药物警戒项目融资模式举隅
Ambrose O Isah,Abimbola O Opadeyi,Henry Tumwijukye et al.
Ambrose O Isah et al.
Background: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the cruc...
Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors [0.03%]
乌干达三级医疗护理中不良药物反应导致的住院负担及其影响因素
Lillian Asio,Marble Nasasira,Ronald Kiguba
Lillian Asio
Background: Adverse drug reactions (ADRs) contribute to the burden of disease globally and of particular concern are ADR-related hospital admissions. Obje...
Flow rate accuracy of infusion devices within healthcare settings: a systematic review [0.03%]
医疗环境中输液装置的流量准确性：系统评价
Opeyemi Atanda,Jonathan West,Tom Stables et al.
Opeyemi Atanda et al.
Background: One in five patients admitted to the hospital treated with intravenous (IV) fluid therapy suffer complications due to inappropriate administration. Errors have been reported in 13-84% of the preparation and ad...
Safety monitoring of oral iron supplements in pregnant women with anemia: a multi-center observational clinical study [0.03%]
口服补铁对妊娠期缺铁性贫血妇女的安全监测多中心临床观察研究
Chang Liu,Qianqian Zhang,Peiye Hui et al.
Chang Liu et al.
Aims: To investigate the safety of oral iron therapy in pregnant women with iron-deficiency anemia (IDA) in the real world. Methods: A ...
Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population [0.03%]
联合使用人群药代动力学和机器学习优化儿科抗癫痫治疗
Ivana Damnjanović,Nastia Tsyplakova,Nikola Stefanović et al.
Ivana Damnjanović et al.
Purpose: Unpredictable drug efficacy and safety of combined antiepileptic therapy is a major challenge during pharmacotherapy decisions in everyday clinical practice. The aim of this study was to describe the pharmacokine...
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study [0.03%]
HER2阳性晚期乳腺癌患者使用β受体阻滞剂的生存结局：一项回顾性队列研究
Hui-Hsia Hsieh,Tien-Yuan Wu,Chi-Hua Chen et al.
Hui-Hsia Hsieh et al.
Background: Clinical trials investigating the effects of beta-blockers (BBs) on cancer are underway. Evidence from preclinical research suggests that BBs could serve as anticancer agents and immune boosters. There is conf...
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study [0.03%]
食品药品监督管理局批准的2012年至2017年间抗糖尿病药物不良反应报告的评价：一项药物警戒研究
Britney A Stottlemyer,Michael C McDermott,Mackenzie R Minogue et al.
Britney A Stottlemyer et al.
Objective: Between 2012 and 2017, the U.S. Food and Drug Administration (FDA) approved 10 antidiabetic indicated therapies. Due to the limited literature on voluntarily reported safety outcomes for recently approved antid...